Tibet Pharmaceuticals, Inc. TBET Securities Stock Fraud

Company:	Tibet Pharmaceuticals, Inc.
Ticker Symbol:	TBET
Class Period:	Dec-28-10 to May-26-12
Date Filed:	May-26-12
Lead Plaintiff Deadline:	Jul-25-12
Court:	-----
Allegations:

New York, NY: A securities class action lawsuit has been filed on behalf of investors who purchased the securities of Tibet Pharmaceuticals, Inc ("Tibet Pharma") (OTC: TBET) anytime after December 28, 2010 (the "Class Period"), seeking to recover damages for violations of the federal securities laws. No class has yet been certified in this action.

The Complaint asserts violations of the federal securities laws against Tibet Pharma, its officers and directors, and underwriters for issuing inaccurate statements of material fact about the Company's true financial and business condition, which ultimately caused the Tibet Pharma's stock to be halted by the NASDAQ and delisted, causing investors to lose nearly their entire investment. The Complaint alleges defendants misrepresented and failed to disclose material internal control deficiencies, which rendered the Company's registration statement and prospectus to be materially false and misleading.

If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.

Tibet Pharmaceuticals, Inc. TBET Securities Fraud Legal Help

If you have suffered from financial losses, you may qualify for damages or remedies that may be awarded in a possible Tibet Pharmaceuticals, Inc. securities class action lawsuit. Please click the link below to submit your complaint for a free evaluation.
Published on May-28-12